Lidocain/Prilocain Adgc

Lidocaine and Prilocaine, the active ingredients in Lidocain/Prilocain Adgc, are local anesthetics presented as a topical formulation for skin and mucous membrane use. They provide reversible loss of sensation to facilitate minor procedures and reduce discomfort.

GNH USA supplies Lidocain/Prilocain Adgc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product is manufactured under EU GMP standards and distributed to meet the needs of healthcare providers across multiple regions.

Lidocaine/Prilocaine is a topical local anesthetic used to temporarily block nerve transmission in the skin and mucous membranes.

- Topical local anesthesia of skin and mucous membranes: provides numbing for minor diagnostic or therapeutic procedures. - Pain relief for minor surgical or diagnostic procedures: reduces discomfort during biopsies, suturing, or laser treatments. - Pre‑operative skin anesthesia: prepares the area before injection or minor surgery to improve patient comfort.

Common Side Effects: - Local irritation or erythema at the application site. - Mild burning or stinging sensation. - Itching or pruritus. - Swelling or edema of the treated area. - Transient numbness extending beyond the intended zone.

Serious or Rare Side Effects: - Allergic contact dermatitis or severe skin reactions. - Methemoglobinemia, especially with extensive use. - Systemic toxicity presenting as CNS symptoms (dizziness, seizures) or cardiovascular depression. - Anaphylaxis or severe hypersensitivity reactions. - Persistent numbness or motor weakness. - Rare cases of tissue necrosis with improper use.

Lidocaine/Prilocaine should be used according to prescriber instructions and with awareness of the following precautions. - Allergy assessment: avoid in patients with known hypersensitivity to amide‑type local anesthetics. - Application area: limit to intact skin or mucosa; do not apply to open wounds or inflamed tissue. - Dosage control: adhere to recommended surface area and duration to prevent systemic absorption. - Patient populations: use cautiously in infants, elderly, or patients with hepatic impairment. - Concomitant anesthetics: avoid simultaneous use of other topical anesthetics to reduce cumulative toxicity. - Store at room temperature: keep in the original container, protect from moisture and light.

Lidocaine/Prilocaine may interact with other medicines; awareness of the following is important.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): increased risk of methemoglobinemia. - Other systemic local anesthetics: additive risk of central nervous system and cardiovascular toxicity. - Sodium channel‑blocking antiarrhythmics: potential for enhanced cardiac effects.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask tachycardia that signals systemic toxicity. - CYP450 inhibitors (e.g., cimetidine): may raise plasma concentrations of the anesthetics. - Alcohol: can potentiate central nervous system depression when systemic absorption occurs.